Background: In light of rising healthcare costs and evidence of inefficient use of medical resources, there is growing interest in reducing healthcare waste by clinicians. Unwarranted lab tests may lead to further tests, prolonged hospital stays, unnecessary referrals and procedures, patient discomfort, and iatrogenic anemia, resulting in significant economic and clinical effects. Blood tests are essential in guiding medical decisions, but they are also associated with significant financial and clinical costs. We designed a quality improvement study that attempted to decrease inappropriate ordering of laboratory tests while maintaining quality of care in a large residency program.
Introduction
Clinical laboratory tests are essential components of the diagnostic armamentarium available to physicians today. Results guide up to 70% of medical decisions [1] . Approximately 4 -5 billion laboratory tests are ordered yearly in the United States [2] , contributing to about 4% of annual healthcare expenditure [3] . In light of rising healthcare costs, there is interest in reducing unnecessary and/or inappropriate ordering of laboratory tests [4] . Results of unwarranted lab tests prompt follow-up diagnostic tests, prolong length of hospital stay (LOS), and promote unnecessary referrals/procedures, patient discomfort, and iatrogenic anemia, all contributing to increased downstream costs [5, 6] .
Various explanations exist for inappropriate lab ordering. In teaching hospitals, lab test ordering is usually performed by interns with attending physician oversight [7] . Interns sometimes order unnecessary lab tests because they may not be able to determine the ideal frequency for monitoring specific parameters. In addition, busy interns face time constraints that make it difficult to weigh the rationale for each individual test [8, 9] . Furthermore, there is variability among attending physicians in determining the appropriateness of a test [10] .
We designed a quality improvement project utilizing resi-Eliminating Healthcare Waste J Clin Med Res. 2017;9(12):965-969 dent education and peer review in an attempt to decrease inappropriate ordering of laboratory tests on the medical in-patient units. We hypothesized that educating residents and encouraging utilization of a study-team-designed ordering algorithm, followed by frequent peer-review, would result in a decrease in the number of lab tests ordered, without clinically significant adverse effects, e.g., increases in mortality and the length of hospitalization.
Methods

Site
Maimonides Medical Center is a 711-bed tertiary hospital in Brooklyn, NY, with over 400 residents and fellows training in various specialties. The internal medicine inpatient teaching service includes interns and residents (supervised by faculty attending physicians) assigned to four unit based teams.
Aims and objectives
This quality improvement (QI) project was approved by the Institutional Review Board. We targeted the most commonly ordered lab tests: complete blood count (CBC), basic metabolic profile (BMP), and coagulation profile (PT/INR). The study population included patients admitted to internal medicine units from November 1, 2013 to April 1, 2015. Data collection included patients admitted from August 1, 2013 to October 31, 2013, in order to assess ordering behavior in the pre-intervention phase for comparison purposes. An ordering algorithm was formulated to guide residents ordering of lab tests ( Fig. 1 ).
Intervention
The study team initiated a multi-pronged intervention on October 31, 2013, beginning with lectures for the residents. Lectures outlined the high-value cost conscious care approach to lab ordering and introduced the study-team-designed ordering algorithm. Thereafter, the study team formed subgroups assigned to each inpatient team which conducted regular surveillance and assessed progress. The hospital's clinical analytics department provided patient demographic data, and the finance department provided details about cost of labs.
Statistical analysis
The "pre-intervention phase" was the 3 months preceding the start of the intervention (August 1, 2013 to October 31, 2013). The same months during the intervention period (August 1, 2014 to October 31, 2014) were selected for comparison to attempt to minimize seasonal changes on variables (defined as the "selected intervention phase"). The primary outcome was a comparison of mortality before and after the introduction of the QI project. We calculated a 5.3% mortality rate, from the data provided by the clinical and quality analytic team in the pre-intervention phase and estimated that the mortality rate during the selected intervention phase would be ±2%. A twogroup Chi-square test was used to determine clinically significant differences in mortality rates between the pre-intervention and selected intervention phases. Secondary endpoints included changes in laboratory costs and changes in LOS. A sample of 2,185 patients/period was estimated to provide at least 80% power to detect any difference in rate of mortality greater than 2% with alpha of 0.05. We estimated that we needed to collect data for approximately 5,000 patients in order to have a reliable estimate of mortality rate.
Results
During the 21-month study period, 9,156 patients were admitted to the hospital units (excluding intensive care units) staffed by medical residents: 1,314 (14%) during the pre-intervention phase from August to October 2013, and 7,842 (86 %) patients during the entire intervention period from November 2013 to April 2015. The actual mortality rate was 5.3% for the pre-intervention phase, and 5.8% for the selected intervention phase (P = 0.44). The average LOS for the pre-intervention phase was 5.61 days, while LOS for the selected intervention phase was 6.45 days, with a difference of 0.85 day.
A comparison of the number of laboratory tests between the pre-intervention phase and selected intervention phase showed a decrease in all types of tests. CBC orders were decreased by 9.3% (9,763 to 8,854), and BNP orders by 12.4% (9,999 to 8,755). The most significant decrease was seen in PT/ INR orders, which was decreased by 20.6% (2,969 to 2,358). Summary data for the number of laboratory tests ordered during the entire period (Fig. 2) revealed a similar trend, with decrease in the number of all types of laboratory tests. The 3-month total cost for CBC, BMP, and PT/INR was $164,973 for the pre-intervention phase, versus $143,573 for the selected intervention phase, resulting in a $21,400 cost saving (Table  1 ). Extrapolating to a full year yielded an estimated $85,600 savings per year.
Discussion
The primary objective of the study was to implement high-value cost conscious care without negatively impacting the quality of care. The advantages of reducing unnecessary lab test orders included the elimination of false positive results that may lead to unnecessary downstream testing. Benefits to the patient included elimination of painful phlebotomy attempts and associated complications such as hematomas, superficial vein thrombosis, and skin infections, leading to improved patient experience. The elimination of excessive venipunctures was perhaps of greatest benefit in hospice patients, since diagnostic lab testing did not necessarily improve outcomes and caused discomfort. Our study supported the hypothesis that decreasing the frequency and number of laboratory investigations did not produce a significant difference in mortality. Our study demonstrated a 9.3% reduction in the number of BMPs ordered, 12.4% reduction in CBC tests and 20.6% decrease in PT/INR tests, leading to a cost savings of $21,400.
We observed a small increase in LOS of 0.8 day; however, this difference was less than 1 day, which was the pre-established limit to define clinically significant change. We identified multiple factors that may have accounted for this increase in average LOS. In October 2013, Centers for Medicare and Medicaid Services (CMS) implemented the two-midnight rule, dictating that inpatient admissions of Medicare and Medicaid patients would be only reimbursed if LOS spanned at least two midnights. This favored admission of patients likely to require longer stays, and prompted emergency room (ER) discharge of those likely to require short inpatient stays. A reduction in inpatient bed capacity (August 2014) may have impacted the increase in LOS in the selected intervention phase. The closure of approximately 30 beds led to an increase in the duration of ER stay for admitted patients prior to bed assignment, since increased ER dwell time is an independent risk factor for prolonged LOS [11] .
Several studies have shown that overutilization of laboratory tests is responsible for major costs in healthcare expenditure in teaching hospitals and a reduction in ordering these tests leads to considerable healthcare savings [1] , which was one of the objectives of our study.
Limitations
We were unable to obtain data on individual patients with International Classification of Diseases, ninth revision (ICD-9) diagnoses, and thus could not perform subgroup analysis for change in LOS. Hawthorne effect may have played a role in the reduction in lab test ordering observed in our study. Study team members who performed peer-review were required to contact the interns that had ordered inappropriate lab tests and provide re-education.
Conclusion
Healthcare waste is a multi-billion-dollar problem and every healthcare provider must carefully weigh costs (including downstream costs), harms, and benefits and order only those interventions that add value to a patient's care. We advocate the use of evidence-based guidelines and decision support tools to practice high-value care. 
